Innopharma, Inc. was acquired by Pfizer, Inc on September 25, 2014. https://www.pfizer.com/news/press-release/press-release-detail/pfizer_completes_acquisition_of_innopharma -------------------------------------------------------------------------------------------------------------------------------------------------------- InnoPharma, Inc. develops niche generic and specialty pharmaceutical/bio-pharmaceutical products in sterile dosage forms, and out-licenses to pharmaceutical marketing companies for commercialization. The “Niche Generics” program is targeted on developing those generic drug products that are: •Difficult to develop for technical reasons, especially injectable and ophthalmic dosage forms •None or very limited API source •Niche area of use •Complicated manufacturing •Complicated bio-equivalency or clinical studies •Potential to provide value to patients and prescribers, in terms of cost effectiveness Visit us at: http://innopharmainc.com
Looking for a particular InnoPharma, Inc. employee's phone or email?
InnoPharma, Inc. Questions
The InnoPharma, Inc. annual revenue was $8.1 million in 2026.
2 people are employed at InnoPharma, Inc..
InnoPharma, Inc. is based in Piscataway, New Jersey.
The NAICS codes for InnoPharma, Inc. are [32541, 3254, 541, 54, 5417, 325, 32].
The SIC codes for InnoPharma, Inc. are [283, 28].
Top InnoPharma, Inc. Employees
Related Companies
